TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells
Author(s) -
Matthias Vanderkerken,
Bastiaan Maes,
Lana Vandersarren,
Wendy Toussaint,
Kim Deswarte,
Ma Vanheerswynghels,
Philippe Pouliot,
Liesbet Martens,
Sofie Van Gassen,
Connie M. Arthur,
Margaret E. Kirkling,
Boris Reizis,
Daniel H. Conrad,
Sean R. Stowell,
Hamida Hammad,
Bart N. Lambrecht
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2009847117
Subject(s) - microbiology and biotechnology , biology , kinase , dendritic cell , immune system , spleen , acquired immune system , innate immune system , immunology
Antigen-presenting conventional dendritic cells (cDCs) are broadly divided into type 1 and type 2 subsets that further adapt their phenotype and function to perform specialized tasks in the immune system. The precise signals controlling tissue-specific adaptation and differentiation of cDCs are currently poorly understood. We found that mice deficient in the Ste20 kinase Thousand and One Kinase 3 (TAOK3) lacked terminally differentiated ESAM + CD4 + cDC2s in the spleen and failed to prime CD4 + T cells in response to allogeneic red-blood-cell transfusion. These NOTCH2- and ADAM10-dependent cDC2s were absent selectively in the spleen, but not in the intestine of Taok3 -/- and CD11c-cre Taok3 fl/fl mice. The loss of splenic ESAM + cDC2s was cell-intrinsic and could be rescued by conditional overexpression of the constitutively active NOTCH intracellular domain in CD11c-expressing cells. Therefore, TAOK3 controls the terminal differentiation of NOTCH2-dependent splenic cDC2s.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom